Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design
The Source Code of Life
Industry analyst discusses biotech firm lifecycle
ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie
Innovation at the intersection of design and technology
Is AI delivering on the hype?
EU New Role as Tech Venture Capitalist
Fund commits to $350M dedicated LS investments
UBS clients raise $650 mln for biggest yet biotech impact fund
Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
